Kursprognose für Arvinas Inc (ARVN)ARVNArvinas Inc

Alphio's ARVN stock price prediction model matches the current Arvinas Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.42 (+1.59%). The 1-week path is $6.88 (-5.69%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Arvinas Inc (ARVN) is not a good buy. The stock is trading at $6.97, significantly below its recent analyst price targets, which range from $10 to $21. The RSI is at 35.88, indicating that the stock is oversold, but the negative momentum in the stock's price, down 39.23% year-to-date, raises concerns. Additionally, insider selling has increased by 504.89%, signaling a lack of confidence from those closest to the company. While there are potential future revenue opportunities from FDA approvals and licensing deals, the current financial instability, including a net income loss of $57.6 million in Q1 2026, poses a significant risk.

Arvinas Inc (ARVN) last closed at $7.3, losing -5.44%. These facts feed the 1-day and 1-week ARVN price prediction above.